Skip to Main Content

Skip Nav Destination

Article navigation

Drug Update| April 01 2012

Efficacy and Safety of Pharmacological Options for Rate Control in Atrial Fibrillation

Katie O’Brien, PharmD;

Katie O’Brien, PharmD

Katie O’Brien is Clinical Pharmacist, Tampa General Hospital, 1 Tampa General Circle, Tampa, FL 33606 (ko’brien@tgh.org). Earnest Alexander is Clinical Manager, Department of Pharmacy Services, and Critical Care Pharmacy Residency Program Director, Tampa General Hospital, Tampa, Florida. Lindsay Patel is Clinical Pharmacist, Tampa General Hospital, Tampa, Florida.

Search for other works by this author on:

PubMed

Google Scholar

Earnest Alexander, PharmD;

Earnest Alexander, PharmD

Katie O’Brien is Clinical Pharmacist, Tampa General Hospital, 1 Tampa General Circle, Tampa, FL 33606 (ko’brien@tgh.org). Earnest Alexander is Clinical Manager, Department of Pharmacy Services, and Critical Care Pharmacy Residency Program Director, Tampa General Hospital, Tampa, Florida. Lindsay Patel is Clinical Pharmacist, Tampa General Hospital, Tampa, Florida.

Search for other works by this author on:

PubMed

Google Scholar

Lindsay Patel, PharmD, BCPS

Lindsay Patel, PharmD, BCPS

Katie O’Brien is Clinical Pharmacist, Tampa General Hospital, 1 Tampa General Circle, Tampa, FL 33606 (ko’brien@tgh.org). Earnest Alexander is Clinical Manager, Department of Pharmacy Services, and Critical Care Pharmacy Residency Program Director, Tampa General Hospital, Tampa, Florida. Lindsay Patel is Clinical Pharmacist, Tampa General Hospital, Tampa, Florida.

Search for other works by this author on:

PubMed

Google Scholar

AACN Adv Crit Care (2012) 23 (2): 120–125.

https://doi.org/10.4037/NCI.0b013e318242fdd0

You do not currently have access to this content.

Don't already have an account? Register